Advertisement

Topics

Public offering nets $23.3mm for Vical

14:40 EST 10 Nov 2017 | Elsevier Business Intelligence

Vical Inc. (infectious disease therapies) netted $23.3mm through a public offering of 7mm common shares at $1.75 and 7.2mm pr...

Original Article: Public offering nets $23.3mm for Vical

NEXT ARTICLE

More From BioPortfolio on "Public offering nets $23.3mm for Vical"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...